Transparency Market Research

Hospital Acquired Disease Testing Market to Hit US$7.5 Billion by 2019 : TMR

A new report on the global hospital acquired disease testing market, titled “Hospital Acquired Disease Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019”, has been recently announced by Transparency Market Research (TMR), a U.S based market intelligence firm.


Albany, NY -- (SBWIRE) -- 02/25/2015 -- The report states that the global hospital acquired disease testing market, which valued US$2.2 billion in 2012, could achieve growth at a healthy CAGR of 19.3% between 2013 and 2019 and value nearly US$7.5 billion by 2019.

Hospital acquired diseases/nosocomial infections/hospital associated infections represent a segment in the healthcare industry that needs critical focus. The market of hospital acquired disease testing, a market comprising services and products associated with testing methods used to diagnose hospital acquired diseases, has bloomed in the past few years due to many factors. Some of these factors include the rising prevalence of such diseases in the geriatric and neonatal population on the global front and a steady rise in government initiatives for managing these conditions.

The report studies the global hospital acquired disease testing market on the basis of the most common types of hospital acquired diseases and the chief regional markets that help this industry acquire its majority percent revenue shares.

Get Sample Report :

Amongst the various types of infections covered by the report, the segment hospital acquired urinary tract infection testing acquired the majority percent revenue shares of the overall market in 2012 due to high prevalence and morbidity rates associated with condition. This segment of the global hospital acquired disease testing market is expected to grow at a healthy CAGR of 18.1% during the forecast period, and value nearly US$2,188.8 million by 2019. Demand for diagnostic services for conditions such as pneumonia and surgical site infections is also expected to remain high from lesser developed countries in the Asia-Pacific regions. Market of this segment is expected to grow at a CAGR of 20.1% during the forecast period.

Throughout the global hospital acquired disease testing market, the regional markets of United States and Canada together accounted for nearly 41.3% shares of revenues in 2012. Some factors that led to a blooming growth of the hospital acquired disease testing industry in these regions include strict implementation of healthcare guidelines laid down by institutions such as the US Centers for Disease Control and Prevention, and highly sophisticated healthcare infrastructure.

Browse Press Release :

Public health systems in the European Union are encouraging the coordination between medical practitioners and healthcare providers to cooperatively come up with better, faster, and economic methods for the management and prevention of nosocomial diseases. Countries in the Asia Pacific represent the markets with huge growth potential for the global hospital acquired disease testing market due to factors such as poor infrastructure, high population and lack of adherence to sanitation practices.

Browse the full Hospital Acquired Disease Testing Market (Pneumonia, UTI, Blood Stream, Surgical Site, MRSA Infection, and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 report at

The highly fragmented market has many large and mid-sized businesses operating amid intense competition. Some of the key players in the market include Qiagen GmbH, L Hoffman La Roche, Cepheid, Inc., Cantel Medical Corporation, Life Technologies Corporation, Diatherix Laboratories Inc., Nordion, Inc., Gen-Probe Inc., and Meridian Biosciences, among others.

About Transparency Market Research
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with a highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact :
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Blog :